grateful to Dr Bolger and Ramakrishnan for pointing out the reference omission and for the opportunity to reply.
The value of radiotherapy for the treatment of adenocarcinoma of the gallbladder is still controversial and any detected improvement in survival reported is measured only in terms of months. Houry et al.1 report the largest series of patients followed after radiotherapy treatment. Their study suggests that there was some improvement in those patients treated after palliative surgery, or with unresectable lesions. There is no evidence available to support the use of routine adjuvant radiotherapy for in situ or intramucosal lesions.
With regard to the comments by Dr Penman, the question arises as to what subsequent treatment should be offered after resection of an occult carcinoma of the gallbladder. For in situ tumours, cholecystectomy may suffice. However, invasive carcinoma, despite its poor prognosis, probably demands further local wedge resection of the gallbladder bed, with clearance of nodes at the porta to confirm staging of the disease. If gallbladder carcinoma is suspected at elective cholecystectomy, frozen section examination is recommended, to allow decision on further treatment to be made at the initial operation.
Mr Carty and Johnston reiterate that patients with intramucosal disease alone still have a relatively poor 5-year survival rate. The controversies concerning treatment of early adenocarcinoma of the gallbladder may justify creation of a national register of cases, to determine the true incidence and prevalence of the disease and to establish the current consensus on treatment. P BURGESS P D MURPHY M B CLAGUE I would feel that passing a guide wire or dilatation system under direct vision would be superior in terms of a lower complication rate than passing a dilator or guide wire system under fluoroscopic control, especially for more proximal colonic strictures. is an essential first step to elucidate the aetiology of the colonic stricture and therefore colonoscopy, with an accepted low complication rate, is not avoided. There are two methods of colonoscopic balloon dilatation. The first is passing a guide wire alongside the colonoscope, under direct vision. The balloon catheter, with a maximum diameter up to 40 mm, is then passed over the guide wire. For accurate placement, fluoroscopic screening can be used or the colonoscope can be re-inserted and the position of the balloon viewed directly. The second method is to pass the complete balloon dilatation system (Radiologic Limited, Letchworth) which is 2.8 mm in diameter, down the biopsy channel. The catheter can be positioned accurately, without removing the colonoscope. Strictures, even less than 1 em, can be dilated up to 28 mm. Following this direct visualization of the proximal bowel is possible through the colonoscope.
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